Medibio is a mental health technology company that has pioneered the use of objective digital biomarkers to assist in the screening, diagnosing, monitoring, and management of depression and other mental health conditions. The Company was founded in Australia, with offices in Australia and Minneapolis, MN, U.S. Medibio is listed on the Australian Securities Exchange Ltd and trades on the OTCQB Venture Market.